Logo image of EXN

EXCELLON RESOURCES INC (EXN) Stock Fundamental Analysis

NYSEARCA:EXN - NYSE Arca - CA30069C8016 - Common Stock - Currency: USD

0.295  -0.01 (-4.13%)

After market: 0.273 -0.02 (-7.46%)

Fundamental Rating

1

EXN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 150 industry peers in the Metals & Mining industry. Both the profitability and financial health of EXN have multiple concerns. EXN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year EXN has reported negative net income.
EXN had a positive operating cash flow in the past year.
EXN Yearly Net Income VS EBIT VS OCF VS FCFEXN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -10M -20M -30M -40M -50M

1.2 Ratios

EXN has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXN Yearly ROA, ROE, ROICEXN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 500 1K

1.3 Margins

EXN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EXN Yearly Profit, Operating, Gross MarginsEXN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -50 -100 -150

More info and screens

0

2. Health

2.1 Basic Checks

EXN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EXN has been increased compared to 1 year ago.
Compared to 1 year ago, EXN has a worse debt to assets ratio.
EXN Yearly Shares OutstandingEXN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
EXN Yearly Total Debt VS Total AssetsEXN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

2.2 Solvency

EXN has an Altman-Z score of -8.59. This is a bad value and indicates that EXN is not financially healthy and even has some risk of bankruptcy.
EXN has a Altman-Z score of -8.59. This is amonst the worse of the industry: EXN underperforms 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.59
ROIC/WACCN/A
WACC8.4%
EXN Yearly LT Debt VS Equity VS FCFEXN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M

2.3 Liquidity

EXN has a Current Ratio of 0.21. This is a bad value and indicates that EXN is not financially healthy enough and could expect problems in meeting its short term obligations.
EXN has a worse Current ratio (0.21) than 95.92% of its industry peers.
A Quick Ratio of 0.18 indicates that EXN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.18, EXN is doing worse than 95.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.18
EXN Yearly Current Assets VS Current LiabilitesEXN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

EXN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -110.00%.
Looking at the last year, EXN shows a very negative growth in Revenue. The Revenue has decreased by -13.57% in the last year.
The Revenue has been growing by 17.44% on average over the past years. This is quite good.
EPS 1Y (TTM)-110%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.04%
Revenue 1Y (TTM)-13.57%
Revenue growth 3Y16.01%
Revenue growth 5Y17.44%
Sales Q2Q%-23.7%

3.2 Future

EXN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.95% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y71.94%
EPS Next 2Y32.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EXN Yearly Revenue VS EstimatesEXN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
EXN Yearly EPS VS EstimatesEXN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EXN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EXN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EXN Price Earnings VS Forward Price EarningsEXN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EXN Per share dataEXN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as EXN's earnings are expected to grow with 32.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.95%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EXN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EXCELLON RESOURCES INC

NYSEARCA:EXN (1/30/2023, 8:04:01 PM)

After market: 0.273 -0.02 (-7.46%)

0.295

-0.01 (-4.13%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-08 2022-11-08/bmo
Earnings (Next)03-29 2023-03-29/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.81M
Analysts80
Price Target0.77 (161.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-55.59%
Min EPS beat(2)-55.59%
Max EPS beat(2)-55.59%
EPS beat(4)0
Avg EPS beat(4)-819.38%
Min EPS beat(4)-1583.17%
Max EPS beat(4)-55.59%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.49%
PT rev (3m)4.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF 20.71
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.26
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.01
OCFY4.83%
SpS0.89
BVpS-0.35
TBVpS-0.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.48%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.18
Altman-Z -8.59
F-Score4
WACC8.4%
ROIC/WACCN/A
Cap/Depr(3y)127.64%
Cap/Depr(5y)126.18%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-110%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.04%
EPS Next Y71.94%
EPS Next 2Y32.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.57%
Revenue growth 3Y16.01%
Revenue growth 5Y17.44%
Sales Q2Q%-23.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-51.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y80.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y108.57%
OCF growth 3YN/A
OCF growth 5YN/A